Efficacy and Safety Study of Ulipristal Acetate in Females With Anemia Associated With Uterine Leiomyoma
- Registration Number
- NCT01553123
- Lead Sponsor
- Watson Pharmaceuticals
- Brief Summary
The purpose of this study is to determine whether ulipristal acetate is effective in the treatment of females with anemia associated with uterine leiomyomas. The safety of this product will also be evaluated.
- Detailed Description
This is a randomized, placebo controlled, multicenter study with parallel groups in order to evaluate the efficacy and safety of ulipristal acetate in female subjects with anemia associated with uterine leiomyomas. The objective of this study is to determine if daily ulipristal acetate with iron is more effective than iron alone.
Recruitment & Eligibility
- Status
- WITHDRAWN
- Sex
- Female
- Target Recruitment
- Not specified
- Is a pre-menopausal female, 18 - 50 years;
- Has documented leiomyoma(s);
- Has leiomyoma-related anemia;
- Has an endometrial biopsy within the screening period prior to the first dose of the test article which shows no endometrial hyperplasia;
- Is willing and able to provide written informed consent and authorization to disclose protected health information.
- Has a history of uterine surgery that would interfere with the study;
- Has a condition requiring immediate or intermittent blood transfusions;
- Has a known coagulation disorder;
- Has a history of uterine, cervix, ovarian, or breast cancer;
- Has used a selective progesterone receptor modulator or a gonadotrophin releasing hormone agonist in previous 6 months;
- Has received blood transfusion within 8 weeks before the screening visit;
- Has abnormal liver functions;
- Is pregnant.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Ulipristal with iron Ulipristal Acetate - Ulipristal with iron Iron - Placebo Iron Placebo with iron
- Primary Outcome Measures
Name Time Method Change from baseline in hemoglobin levels (g/dL) Day 1 of the first on-treatment menstrual cycle to the start, or scheduled start of menstrual cycle 3. Change from baseline in hemoglobin levels (g/dL)
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (46)
Discovery Clinical Trials - Genesis Health Central Women's Care
๐บ๐ธDallas, Texas, United States
Lawrence Obstetrics-Gynecology Clinical Research
๐บ๐ธLawrenceville, New Jersey, United States
Columbus Center for Women's Health Research
๐บ๐ธColumbus, Ohio, United States
Office of Annette Mayes, MD, PC
๐บ๐ธLas Vegas, Nevada, United States
Office of Edmond Pack, MD
๐บ๐ธLas Vegas, Nevada, United States
Office of R. Garn Mabey, Jr
๐บ๐ธLas Vegas, Nevada, United States
Advances in Health Inc
๐บ๐ธHouston, Texas, United States
Sharp Rees-Stealy Medical Group
๐บ๐ธSan Diego, California, United States
Alabama Clinical Therapeutics
๐บ๐ธBirmingham, Alabama, United States
Women's Health Research
๐บ๐ธPhoenix, Arizona, United States
Medical Center for Clinical Research
๐บ๐ธSan Diego, California, United States
Hutzel Womens Health Specialists
๐บ๐ธDetroit, Michigan, United States
Clinical Trials of Texas Incorporated Laboratory
๐บ๐ธSan Antonio, Texas, United States
Downtown Women's Health Care
๐บ๐ธDenver, Colorado, United States
Visions Clinical Research
๐บ๐ธBoynton Beach, Florida, United States
Healthcare Clinical Data, Inc.
๐บ๐ธNorth Miami, Florida, United States
South Bend Clinical
๐บ๐ธGranger, Indiana, United States
Benchmark Research
๐บ๐ธSacramento, California, United States
Coastal Clinical Research, Inc
๐บ๐ธMobile, Alabama, United States
Altus Research
๐บ๐ธLake Worth, Florida, United States
Jacksonville Center for Clinical Research
๐บ๐ธJacksonville, Florida, United States
Atlanta Women's Research Institute, Inc
๐บ๐ธAtlanta, Georgia, United States
Comprehensive Clinical Trials, LLC
๐บ๐ธWest Palm Beach, Florida, United States
Fellows Research Alliance
๐บ๐ธSavannah, Georgia, United States
Women's Health Practice
๐บ๐ธChampaign, Illinois, United States
All Women's Healthcare of West Broward
๐บ๐ธPlantation, Florida, United States
Physician Care Clinical Research, LLC
๐บ๐ธSarasota, Florida, United States
Praetorian Pharmaceutical Research, LLC
๐บ๐ธMarrero, Louisiana, United States
Center for Women's Research
๐บ๐ธPalos Heights, Illinois, United States
Mount Vernon Clinical Research, LLC
๐บ๐ธSandy Springs, Georgia, United States
Women Under Study, LLC
๐บ๐ธNew Orleans, Louisiana, United States
Advanced Gynecologic Surgery Institute
๐บ๐ธNaperville, Illinois, United States
New York Center for Women's Health Research
๐บ๐ธNew York City, New York, United States
Women's Clinic of Lincoln, P.C.
๐บ๐ธLincoln, Nebraska, United States
Carolina Women's Research and Wellness Center
๐บ๐ธDurham, North Carolina, United States
Southwest Clinical Research
๐บ๐ธAlbuquerque, New Mexico, United States
Physicians for Women of Greensboro
๐บ๐ธGreensboro, North Carolina, United States
Eastern Carolina Women's Center
๐บ๐ธNew Bern, North Carolina, United States
PMG Research of Wilmington
๐บ๐ธWilmington, North Carolina, United States
Wake Research Associates
๐บ๐ธRaleigh, North Carolina, United States
Hawthorne Medical Research
๐บ๐ธWinston-Salem, North Carolina, United States
Southeast Regional Research Group
๐บ๐ธAiken, South Carolina, United States
Advanced Clinical Concepts
๐บ๐ธWest Reading, Pennsylvania, United States
South Carolina Clinical Research Center, LLC
๐บ๐ธColumbia, South Carolina, United States
Willowbend Health and Wellness Associates
๐บ๐ธPlano, Texas, United States
Riverside Regional Medical Center
๐บ๐ธNewport News, Virginia, United States